vs
Niagen Bioscience, Inc.（NAGE）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
Niagen Bioscience, Inc.的季度营收约是REDWOOD TRUST INC的1.3倍（$33.8M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs 12.2%，领先65.0%），Niagen Bioscience, Inc.同比增速更快（16.2% vs -6.1%），过去两年Niagen Bioscience, Inc.的营收复合增速更高（23.6% vs -41.0%）
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
NAGE vs RWT — 直观对比
营收规模更大
NAGE
是对方的1.3倍
$25.9M
营收增速更快
NAGE
高出22.3%
-6.1%
净利率更高
RWT
高出65.0%
12.2%
两年增速更快
NAGE
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.8M | $25.9M |
| 净利润 | $4.1M | $20.0M |
| 毛利率 | 64.1% | — |
| 营业利润率 | 12.1% | — |
| 净利率 | 12.2% | 77.2% |
| 营收同比 | 16.2% | -6.1% |
| 净利润同比 | -42.4% | 402.6% |
| 每股收益（稀释后） | $0.05 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAGERWT
| Q4 25 | $33.8M | $25.9M | ||
| Q3 25 | $34.0M | $15.0M | ||
| Q2 25 | $31.1M | $13.8M | ||
| Q1 25 | $30.5M | $27.9M | ||
| Q4 24 | $29.1M | $27.6M | ||
| Q3 24 | $25.6M | $25.5M | ||
| Q2 24 | $22.7M | $67.4M | ||
| Q1 24 | $22.2M | $74.5M |
净利润NAGERWT
| Q4 25 | $4.1M | $20.0M | ||
| Q3 25 | $4.6M | $-7.7M | ||
| Q2 25 | $3.6M | $-98.5M | ||
| Q1 25 | $5.1M | $16.1M | ||
| Q4 24 | $7.2M | $-6.6M | ||
| Q3 24 | $1.9M | $14.8M | ||
| Q2 24 | $-15.0K | $15.5M | ||
| Q1 24 | $-492.0K | $30.3M |
毛利率NAGERWT
| Q4 25 | 64.1% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 65.0% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 62.5% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 60.2% | — | ||
| Q1 24 | 60.7% | — |
营业利润率NAGERWT
| Q4 25 | 12.1% | — | ||
| Q3 25 | 12.5% | -9.0% | ||
| Q2 25 | 10.2% | -679.0% | ||
| Q1 25 | 15.7% | 80.2% | ||
| Q4 24 | 24.4% | -1.3% | ||
| Q3 24 | 6.3% | 86.1% | ||
| Q2 24 | -1.1% | 30.3% | ||
| Q1 24 | -3.3% | 41.3% |
净利率NAGERWT
| Q4 25 | 12.2% | 77.2% | ||
| Q3 25 | 13.5% | -51.4% | ||
| Q2 25 | 11.6% | -712.0% | ||
| Q1 25 | 16.6% | 57.8% | ||
| Q4 24 | 24.6% | -24.0% | ||
| Q3 24 | 7.3% | 58.1% | ||
| Q2 24 | -0.1% | 23.0% | ||
| Q1 24 | -2.2% | 40.6% |
每股收益（稀释后）NAGERWT
| Q4 25 | $0.05 | $0.11 | ||
| Q3 25 | $0.05 | $-0.08 | ||
| Q2 25 | $0.04 | $-0.76 | ||
| Q1 25 | $0.06 | $0.10 | ||
| Q4 24 | $0.10 | $-0.08 | ||
| Q3 24 | $0.02 | $0.09 | ||
| Q2 24 | $0.00 | $0.10 | ||
| Q1 24 | $-0.01 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $76.5M | $982.6M |
| 总资产 | $106.4M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NAGERWT
| Q4 25 | — | $255.7M | ||
| Q3 25 | $64.1M | $226.3M | ||
| Q2 25 | $60.3M | $302.0M | ||
| Q1 25 | $55.5M | $259.9M | ||
| Q4 24 | $44.5M | $245.2M | ||
| Q3 24 | $32.2M | $253.7M | ||
| Q2 24 | $27.7M | $275.6M | ||
| Q1 24 | $27.4M | $275.4M |
总债务NAGERWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益NAGERWT
| Q4 25 | $76.5M | $982.6M | ||
| Q3 25 | $70.7M | $999.0M | ||
| Q2 25 | $64.2M | $1.1B | ||
| Q1 25 | $55.3M | $1.2B | ||
| Q4 24 | $46.1M | $1.2B | ||
| Q3 24 | $34.4M | $1.2B | ||
| Q2 24 | $30.7M | $1.2B | ||
| Q1 24 | $29.0M | $1.2B |
总资产NAGERWT
| Q4 25 | $106.4M | $23.7B | ||
| Q3 25 | $98.1M | $22.6B | ||
| Q2 25 | $91.5M | $21.3B | ||
| Q1 25 | $81.3M | $19.9B | ||
| Q4 24 | $68.3M | $18.3B | ||
| Q3 24 | $56.5M | $18.4B | ||
| Q2 24 | $54.0M | $16.5B | ||
| Q1 24 | $54.1M | $15.1B |
负债/权益比NAGERWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $679.0K | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.16× | -504.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NAGERWT
| Q4 25 | $679.0K | $-10.1B | ||
| Q3 25 | $3.7M | $-2.7B | ||
| Q2 25 | $1.3M | $-2.1B | ||
| Q1 25 | $7.9M | $-2.0B | ||
| Q4 24 | $8.6M | $-5.9B | ||
| Q3 24 | $3.5M | $-2.1B | ||
| Q2 24 | $-264.0K | $-2.0B | ||
| Q1 24 | $295.0K | $-954.2M |
现金转化率NAGERWT
| Q4 25 | 0.16× | -504.15× | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 1.56× | -120.92× | ||
| Q4 24 | 1.20× | — | ||
| Q3 24 | 1.86× | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
RWT
暂无分部数据
